Author: Wang Gary T
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.12, Iss.6, 2002-06, pp. : 845-861
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Preclinical Development of Low Toxicity Drugs: Focus on Zanamivir, an Anti-Influenza Drug
By Dines G.D.
Drug Safety, Vol. 19, Iss. 3, 1998-09 ,pp. :